ArticleFrontiers in immunology2021

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.

Xu-Sheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.